Sponsored
The Analysis of Versant Venture Management, LLC's Holdings & P&L
Currently, Versant Venture Management, LLC holds 8 types of securities in its portfolio with a total value $141.4M. In the most recent quarter, they have increased their positions in IPSC (+12.2M shares, valued at $27.5M); decreased their positions in GLUE (-1.2M shares, valued at $19.8M); initiated new positions in IPSC (+12.2M shares, valued at $27.5M).
1M P&L
-13.1M-7.70%
3M P&L
+1.7M+1.12%
HY P&L
-16.9M-9.72%
P&L figures are estimated based on reported 13F stock holdings and market price changes. They are approximations and may not reflect actual fund performance. Stock split events may also affect the accuracy of these calculations, and we cannot guarantee that all splits have been fully accounted for.
Top Holding Treemap
Top Industries by Value
1Biotechnology140.2M
100.0%
Top Industries by Stock Count
1Biotechnology7 stocks
100.0%
Sponsored
Stock Holdings
TickerCompany NameSharesShares β³%Event DateReport DateHistory
Sponsored
GLUE
-27.42%Monte Rosa Therapeutics, Inc.
Shares3.2M
Event2026-03-31
Filed2026-05-05
IPSC
NewCentury Therapeutics, Inc.
Shares12.2M
Event2026-03-31
Filed2026-05-05
LENZ
0.00%Lenz Therapeutics, Inc.
Shares2.7M
Event2026-03-31
Filed2026-05-05
JBIO
0.00%Jade Biosciences, Inc.
Shares1.5M
Event2026-03-31
Filed2026-05-05
CTNM
0.00%Contineum Therapeutics, Inc.
Shares542.6K
Event2026-03-31
Filed2026-05-05
CRSP
0.00%CRISPR Therapeutics AG
Shares148.8K
Event2026-03-31
Filed2026-05-05
Skye Bioscience, Inc.
0.00%Skye Bioscience, Inc.
Shares2.0M
Event2026-03-31
Filed2026-05-05
TPST
0.00%Tempest Therapeutics, Inc.
Shares269.8K
Event2026-03-31
Filed2026-05-05
Call Option Holdings
No call option holdings data available
No call option holdings data available
Put Option Holdings
No put option holdings data available
No put option holdings data available